Metaclipse Therapeutics

Delivering breakthrough technologies to treat cancer and infectious disease.

Launch date

2012

Employees

Atlanta Georgia (HQ)

Date	Investors	Amount	Round
-	Small Business Innovation Research (SBIR)	N/A	-
Jan 2012	Emory University	N/A	Spinout
Jun 2012	N/A	$200k	Seed
Aug 2013	National Institutes of Health National Cancer Institute (NCI)	$150k	Grant
Jan 2015	Georgia Research Alliance	N/A	Early VC
Apr 2016	UKRI-BBSRC	$2.5m	Grant
Jan 2017	National Institutes of Health	$1.9m	Grant
Feb 2019	N/A	$2.0m	Grant
Aug 2019	N/A	$2.2m	Grant
Jun 2020	National Cancer Institute (NCI)	$2.2m	Grant
Sep 2021	National Cancer Institute (NCI)	$2.0m	Grant
Total Funding		CAD17.9m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Metaclipse Therapeutics